Minocycline Hydrochloride
If you find any inaccurate information, please let us know by providing your feedback here

This article is compiled based on the United States Pharmacopeia (USP) – 2025 Edition
Issued and maintained by the United States Pharmacopeial Convention (USP)
C23H27N3O7 · HCl 493.94
2-Naphthacenecarboxamide, 4,7-bis(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11dioxo-, monohydrochloride,
[4S-(4α,4aα,5aα,12aα)]-;4,7-Bis(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-2-naphthacenecarboxamide monohydrochloride
CAS RN: 13614-98-7; UNII: 0020414E5U.
1 DEFINITION
Minocycline Hydrochloride contains the equivalent of NLT 890 µg and NMT 950 µg of minocycline (C23H27N3O7) per mg, calculated on the anhydrous basis.
2 IDENTIFICATION
Change to read:
A. SPECTROSCOPIC IDENTIFICATION TESTS (197), Infrared Spectroscopy: 197K. (CN 1-May-2020) Dry the Standard and Sample at 100° for 2 h before use.
B. The retention time of the major peak of the Sample solution corresponds to that of the Standard solution, as obtained in the Assay.
3 ASSAY
PROCEDURE
[NOTE-Protect the Standard solution and Sample solution from light, store in a refrigerator, and use within 3 h.]
Mobile phase: Dimethylformamide, tetrahydrofuran, 0.2 M ammonium oxalate, and 0.01 M edetate disodium TS (120:80:600:180). Adjust with ammonium hydroxide to a pH of 7.2.
System suitability solution: Dissolve 10 mg of USP Minocycline Hydrochloride RS in 20 mL of 0.2 M ammonium oxalate. Heat on a water bath at 60° for 3 h, allow to cool, and dilute with water to 25.0 mL.
Standard solution: Equivalent to 500 µg/mL of minocycline (C23H27N3O7) from USP Minocycline Hydrochloride RS in water
Sample solution: Equivalent to 500 µg/mL of minocycline (C23H27N3O7) from Minocycline Hydrochloride in water
Chromatographic system
(See Chromatography (621), System Suitability.)
Mode: LC
Detector: UV 280 nm
Column: 4.6-mm x 25-cm; 5-µm packing 11
Column temperature: 40o
Flow rate: 1.5 mL/min
Injection volume: 20 µL
System suitability
Samples: System suitability solution and Standard solution
[NOTE-The relative retention times for epiminocycline and minocycline are 0.7 and 1.0, respectively.]
Suitability requirements
Resolution: NLT 4.6 between epiminocycline and minocycline, System suitability solution
Tailing factor: 0.9-2.0, Standard solution
Relative standard deviation: NMT 2.0%, Standard solution
Analysis
Samples: Standard solution and Sample solution
Calculate the quantity, in µg/mg, of minocycline (C23H27N3O7) in the portion of Minocycline Hydrochloride taken:
Result = (ru /rs ) × (Cs /Cu ) × P
ru = peak response from the Sample solution
rs = peak response from the Standard solution
Cs = concentration of minocycline in the Standard solution (µg/mL)
Cu = concentration of minocycline in the Sample solution (µg/mL)
P = potency of USP Minocycline Hydrochloride RS (µg/mg)
Acceptance criteria: 890–950 µg/mg on the anhydrous basis
4 IMPURITIES
RESIDUE ON IGNITION (281): NMT 0.15%
ORGANIC IMPURITIES
Mobile phase, System suitability solution, Standard solution, Chromatographic system, and System suitability: Proceed as directed in the
Assay.
[NOTE-Protect the Standard solution and the Sample solutions from light, store in a refrigerator, and use within 3 h.]
Sample solution 1: 0.25 mg/ml of Minocycline Hydrochloride in water
Sample solution 2: 5 µg/mL of Minocycline Hydrochloride in water
Sample solution 3: 3 µg/mL of Minocycline Hydrochloride in water
Run time: 2.6 times the retention time of minocycline, Sample solution 1
Analysis
Samples: Sample solution 1, Sample solution 2, and Sample solution 3
Calculate the percentage of epiminocycline in the portion of Minocycline Hydrochloride taken:
Result = (re1 /rm3 ) × D1 × 100
re1 = peak response of epiminocycline from Sample solution 1
rm3 = peak response of minocycline from Sample solution 3
D1 = dilution factor for Sample solution 3
Calculate the total percentage of impurities other than epiminocycline in the portion of Minocycline Hydrochloride taken:
Result = (rT /rm2 ) × D2 × 100
rT = sum of the peak responses of all impurities other than epiminocycline from Sample solution 1
rm2 = peak response of minocycline from Sample solution 2
D2 = dilution factor for Sample solution 2
Acceptance criteria
Individual impurities: NMT 1.2% epiminocycline
Total impurities (excluding epiminocycline): NMT 2.0%
5 SPECIFIC TESTS
CRYSTALLINITY (695): Meets the requirements
PH (791)
Sample: 10 mg/mL of minocycline in solution
Acceptance criteria: 3.5-4.5
WATER DETERMINATION (921), Method /: 4.3%-8.0%
STERILITY TESTS (71): Where the label states that Minocycline Hydrochloride is sterile, it meets the requirements.
BACTERIAL ENDOTOXINS TEST (85): Where the label states that Minocycline Hydrochloride is sterile or must be subjected to further processing during the preparation of injectable dosage forms, it contains NMT 1.25 USP Endotoxin Units/mg of minocycline.
6 ADDITIONAL REQUIREMENTS
PACKAGING AND STORAGE: Preserve in tight containers, protected from light.
LABELING: Where it is intended for use in preparing injectable dosage forms, the label states that it is sterile or must be subjected to further processing during the preparation of injectable dosage forms.
USP REFERENCE STANDARDS (11)
USP Minocycline Hydrochloride RS

